Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CHARM_UCSD
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CHARM_UCSD
-
Excellent article featuring the perspectives of our most recent CHARM Industry speaker, Mike Dudley of QPex, and highlighting the important impact of the
@CARB_X accelerator for antibiotic innovation.https://www.menshealth.com/health/a30715597/antibiotic-resistance-drug-companies/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Clever proof-of-concept with E. coli, ampicillin-loaded nanoparticles, and Zr-MOF PCN-224-based photodynamic therapy used as backup when resistant (beta-lactamase). Colorimetric Band-aids for Point-of-Care Sensing and Treating Bacterial Infectionhttps://pubs.acs.org/doi/abs/10.1021/acscentsci.9b01104#.XjWRapyyefg.twitter …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CHARM UC San Diego proslijedio/la je Tweet
Bacteria behind tooth decay make antibiotics that take out their competitors https://cen.acs.org/content/cen/articles/98/web/2020/01/Bacteria-behind-tooth-decay-make.html … via
@cenmag@annaedlund@xtang12@moorelabsio@CHARM_UCSD@CMIdigest#microbiomeHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"And of course antibiotics do promote the spread of resistance, but our study indicates that it is primarily through selective population dynamics rather than through an increased rate of plasmid conjugation."https://phys.org/news/2020-01-quarter-bacterial-pathogens-antibiotic-resistance.html …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
CHARM UC San Diego proslijedio/la je Tweet
The
studded lineup of our first @CHARM_UCSD Colloqium of 2020 - Victor Torres (@TorresVJ_Lab) of@nyulangone, Manuela Raffatellu (@mraffatellu) of@UCSDMedSchool and Mike Dudley of#QPEx Biopharma. They each hit it out of the park.pic.twitter.com/ZPoIF0MWve
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
“We still have a window of opportunity but we need to ensure there is investment now so we don’t run out of options for future generations.”https://www.nytimes.com/2020/01/17/health/antibiotics-resistance-new-drugs.html …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CHARM UC San Diego proslijedio/la je Tweet
I am in Singapore for MIT SMART AMR SAB and
@UCSDHealth own Steffanie Strathdee ( @chngin_the_wrld ) and Tom Patterson are here too, at least virtuallypic.twitter.com/Xp5iX1YmHi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
MRSA patients treated with vanco whose strains became tolerant were prone to develop resistance to a second antibiotic ~3x faster. Rationale for up front combo therapy in severe infection? Article in
@ScienceMagazine from Prof. Nathalie Balaban@HebrewU https://science.sciencemag.org/content/367/6474/200 …pic.twitter.com/avS1PERAvX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bacteria Who Don't Play Together, Don't Stay Together Biofilm inhibition strategy in
@NatureComms from@HansSteenackers lab in Leuven, Belgium. https://www.nature.com/articles/s41467-019-13660-x …pic.twitter.com/odpiC2OwKQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
From Médecins Sans Frontières (Doctors Without Borders)https://twitter.com/MSF/status/1216458325811814401 …
4:23Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What are you doing Jan 21? Coming to CHARM Colloquium!pic.twitter.com/lSqVAVabeT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In 2017, the Food and Drug Administration told farmers to stop using antibiotics in animals for growth purposes, but here's the loophole: they are permitted to use them for disease prevention, and there are no reporting requirements.https://www.cbsnews.com/news/is-overuse-of-antibiotics-on-farms-worsening-the-spread-of-antibiotic-resistant-bacteria-60-minutes-2020-01-05/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
CHARM UC San Diego proslijedio/la je Tweet
Protection Against Lethal Multidrug-Resistant Bacterial Infections Using Macrophage Cell Therapy. Josh Sun and Satoshi Uchiyama led our collaboration with
@CellApproaches published in@IMD_Journal http://nizetlab.ucsd.edu/Publications/ICONIMAC.pdf …#antibioticresistance#immunotherapy#macrophagespic.twitter.com/3SKOJ7KTRY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
CHARM UC San Diego proslijedio/la je Tweet
"Behind the Paper"
@NatureComms#CRISPR#GeneDrive#AntibioticResistance#AMR#ProActiveGenetics@ucsdbiosciences@UCSDHealth@CHARM_UCSD Tata Institute for Genetics and Society https://bioengineeringcommunity.nature.com/users/62276-victor-nizet/posts/57702-crispr-based-gene-drives-from-eukaryotes-to-prokaryotes …pic.twitter.com/DMDl5JCOxj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Absolutely - the whole community invited for the learning and networking !https://twitter.com/ShadenAguirre1/status/1208438538502463489 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Katherina Ribbeck of MIT, who gave a special guest seminar in the CHARM early days, is featured in the NIH Director’s Blog.https://directorsblog.nih.gov/2019/12/19/how-mucus-tames-microbes/ …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

